NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
22/02/2024
Voltar para busca
Dado oficial do USPTO
DRUGDEV
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DRUGDEV
ST13
US500000086195494Classe
9, 35, 36, 38, 41, 42
Pedido
86195494
Registro
5293006
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
54
Atualização mais recente
22/02/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 36, 38, 41, 42
Data de depósito
17/02/2014
Data de registro
19/09/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/02/2024
Última transação
22/02/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
704
Cadastro oficial
Supplemental Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Wayne, PA
Examinador
SMIGA, HOWARD
Unidade examinadora
L20
Titulares e representantes
Titulares
DrugDev Inc.
DrugDev Inc.
Representantes
Cynthia Johnson Walden Fish & Richardson P.C.
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 36Classe 38Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Database management software for use in connection with clinical trial investigations; computer software for use in creating searchable databases of information and data; downloadable databases in the field of clinical trial investigations; electronic database in the field of clinical trial investigations; computer software for use in storingadministering and publishing databases on a computer network; computer software for use in controlling online access to information stored in a database via a computer network; computer software for use in payment processing
Classe 35
Compiling and organizing business directories for publication on computer networks; providing an online computer database in the field of collectingcompilingpublishing and administering databases containing information in the field of professional business networking; providing an online computer database in the field of collectingcompilingpublishing and administering databases containing information in the field of professional business networking for advertising purposes; providing business administration advice and related business information services; business research; online professional networking services; databases containing information on professionalsclinical trial physicians; computerized database management; management and compilation of computerized databases
Classe 36
Financial serviceselectronic processing of payment data; financial transfer and transaction administration servicesmoney transfer services and the administration and management of grant payments; payment servicesprocessing electronic payments via a global computer network; bill payment services; payment processing services in the field of clinical trial investigation payments; online collection and distribution of paymentsonline processing of payments from clinical trial sponsors to clinical trial investigators; bill payment servicespayment administration
Classe 38
Providing multiple-user access to global computer information networks for the transfer and dissemination of a wide range of information
Classe 41
Providing an internet website portal featuring entertainment news and information specifically in the field of clinical trial investigations
Classe 42
Providing an online searchable database in the field of clinical trial investigations for scientific research purposes; providing an online computer database in the field of clinical trial investigations for scientific research purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
54 publicações encontradas
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
22/02/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
22/02/2024
ES8R
TEAS SECTION 8 RECEIVED
27/12/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
19/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/10/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/10/2017
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
19/09/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
15/08/2017
EXPT
EXPARTE APPEAL TERMINATED
27/07/2017
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
27/07/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
27/07/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/07/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
27/07/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/07/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/07/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
13/07/2017
EXPI
EX PARTE APPEAL-INSTITUTED
13/07/2017
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
13/07/2017
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
13/07/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
13/01/2017
GNFR
FINAL REFUSAL E-MAILED
13/01/2017
CNFR
FINAL REFUSAL WRITTEN
13/01/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/01/2017
ALIE
ASSIGNED TO LIE
09/01/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
15/12/2016
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
17/06/2016
GNSI
INQUIRY TO SUSPENSION E-MAILED
17/06/2016
CNSI
SUSPENSION INQUIRY WRITTEN
17/06/2016
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
16/06/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/12/2015
GNSL
LETTER OF SUSPENSION E-MAILED
08/12/2015
CNSL
SUSPENSION LETTER WRITTEN
08/12/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/12/2015
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
03/06/2015
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/06/2015
CNSI
SUSPENSION INQUIRY WRITTEN
03/06/2015
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/06/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/12/2014
GNSL
LETTER OF SUSPENSION E-MAILED
03/12/2014
CNSL
SUSPENSION LETTER WRITTEN
03/12/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/12/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2014
ALIE
ASSIGNED TO LIE
26/11/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/11/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/05/2014
GNRT
NON-FINAL ACTION E-MAILED
23/05/2014
CNRT
NON-FINAL ACTION WRITTEN
23/05/2014
DOCK
ASSIGNED TO EXAMINER
22/05/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/02/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DRUGDEV ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.